Submit Deal
All Dealmakers
Similar Dealmakers
Partner at Centerview Partners
Financial Advisor
New York
Share Profile
Deal Bio
Market Context
Awards
Back to top
All rights reserved. Copyright © 2026 Datasite
Expertise (84)
Key Relationships
Sort
Target: MEDIVATION INC.
Bidder: PFIZER INC
2 Service Providers
3 Dealmakers
n/a
Value
Target: KITE PHARMA INC
Bidder: GILEAD SCIENCES
10 Service Providers
24 Dealmakers
£ 9.30 B
Target: ANTELLIQ GROUP
Bidder: MERCK ANIMAL HEALTH
11 Service Providers
30 Dealmakers
£ 2.92 B
Target: SPARK THERAPEUTICS
Bidder: ROCHE HOLDINGS AG
9 Service Providers
29 Dealmakers
£ 3.29 B
Target: CLEMENTIA PHARMACEUTICALS
Bidder: IPSEN
41 Dealmakers
£ 995 M
Target: PELOTON THERAPEUTICS INC
Bidder: MERCK & CO INC
6 Service Providers
42 Dealmakers
£ 824 M
Target: GENOMIC HEALTH
Bidder: EXACT SCIENCES
43 Dealmakers
£ 2.26 B
Target: ACHILLION PHARMACEUTICALS
Bidder: ALEXION PHARMACEUTICALS INC
21 Dealmakers
£ 732 M
Target: SYNTHORX
Bidder: SANOFI SA
50 Dealmakers
£ 1.90 B
Target: ARQULE INC
Bidder: MERCK KGAA
62 Dealmakers
£ 2.05 B
Target: MERCK & CO (WOMEN’S HEALTH, TRUSTED LEGACY BRANDS, AND BIOSIMILARS BUSINESSES)
Bidder: INSTITUTIONAL INVESTORS
8 Service Providers
20 Dealmakers
£ 5.39 B
Target: PIONYR IMMUNOTHERAPEUTICS INC
7 Service Providers
£ 221 M
Target: EIDOS THERAPEUTICS
Bidder: BRIDGEBIO PHARMA LLC
16 Dealmakers
£ 757 M
Target: BIOSPECIFICS TECHNOLOGIES CORP
Bidder: ENDO PHARMACEUTICALS
26 Dealmakers
£ 487 M
Target: VELOSBIO INC
17 Service Providers
55 Dealmakers
£ 2.12 B
Target: PREVAIL THERAPEUTICS
Bidder: ELI LILLY AND COMPANY
36 Dealmakers
£ 778 M
Target: CANTEL MEDICAL CORP
Bidder: STERIS PLC
45 Dealmakers
£ 2.65 B
Target: PANDION THERAPEUTICS INC
28 Dealmakers
£ 1.31 B
Target: CONSTELLATION PHARMACEUTICALS
Bidder: MORPHOSYS AG
13 Service Providers
58 Dealmakers
£ 1.20 B
Target: TRANSLATE BIO
12 Service Providers
52 Dealmakers
£ 2.30 B
Target: IMMUNOVANT SCIENCES LTD
Bidder: ROIVANT SCIENCES LTD
4 Service Providers
12 Dealmakers
£ 143 M
Target: VIVIDION THERAPEUTICS
Bidder: BAYER AG
47 Dealmakers
£ 1.44 B
Target: TRILLIUM THERAPEUTICS INC
£ 1.66 B
Target: SANIFIT THERAPEUTICS
Bidder: VIFOR PHARMA AG
14 Dealmakers
£ 314 M
Target: LENGO THERAPEUTICS
Bidder: BLUEPRINT MEDICINES
57 Dealmakers
£ 348 M
Target: ARENA PHARMACEUTICALS
£ 5.05 B
Target: AMUNIX PHARMACEUTICALS
5 Service Providers
£ 756 M
Target: REVIRAL
27 Dealmakers
£ 401 M
Target: CHECKMATE PHARMACEUTICALS
Bidder: REGENERON PHARMACEUTICALS INC
£ 191 M
Target: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD
46 Dealmakers
£ 9.42 B
Target: MIROBIO
£ 333 M
Target: FORMA THERAPEUTICS
Bidder: NOVO NORDISK
65 Dealmakers
£ 944 M
Target: AKOUOS
22 Dealmakers
£ 539 M
Target: DJS ANTIBODIES
Bidder: ABBVIE INC
37 Dealmakers
£ 227 M
Target: FAMY LIFE SCIENCES
Bidder: VIATRIS
£ 659 M
Target: IMAGO BIOSCIENCES
£ 1.14 B
Target: TMUNITY THERAPEUTICS
Bidder: KITE PHARMA INC
Target: AMRYT PHARMA PLC
Bidder: CHIESI FARMACEUTICI SPA
44 Dealmakers
£ 1.22 B
Target: ALBIREO PHARMA
£ 786 M
Target: CINCOR PHARMA
Bidder: ASTRAZENECA PLC
79 Dealmakers
£ 1.49 B
Target: PROVENTION BIO
76 Dealmakers
£ 2.41 B
Target: PROMETHEUS BIOSCIENCES INC
£ 8.70 B
Target: BELLUS HEALTH
Bidder: GLAXOSMITHKLINE PLC
17 Dealmakers
£ 1.61 B
Target: VECTIVBIO
Bidder: IRONWOOD PHARMACEUTICALS INC
18 Service Providers
£ 803 M
Target: CHINOOK THERAPEUTICS
Bidder: NOVARTIS AG
75 Dealmakers
£ 2.78 B
Target: PFIZER (PRECLINICAL GENE THERAPY PROGRAMS)
£ 779 M
Target: DECIBEL THERAPEUTICS
£ 167 M
Target: INVERSAGO PHARMA
3 Service Providers
£ 843 M
Target: POINT BIOPHARMA
40 Dealmakers
£ 1.15 B
Target: GRACELL BIOTECHNOLOGIES INC
34 Dealmakers
£ 971 M
Target: RAYZEBIO
Bidder: BRISTOL MYERS SQUIBB COMPANY
£ 3.23 B
Target: HARPOON THERAPEUTICS
63 Dealmakers
£ 534 M
Target: MORPHOSYS AG
116 Dealmakers
£ 2.31 B
Target: AMOLYT PHARMA
£ 820 M
Target: FUSION PHARMACEUTICALS
68 Dealmakers
£ 1.57 B
Target: CARDIOR
£ 879 M
Target: INHIBRX
£ 1.34 B
Target: MARIANA ONCOLOGY
48 Dealmakers
£ 1.40 B
Target: PROTEOLOGIX
Bidder: JOHNSON & JOHNSON
18 Dealmakers
£ 672 M
Target: YELLOW JERSEY THERAPEUTICS
15 Dealmakers
£ 979 M
Target: EYEBIOTECH
£ 2.35 B
Target: MORPHIC HOLDING INC
53 Dealmakers
£ 2.50 B
Target: IRONSHORE THERAPEUTICS
Bidder: COLLEGIUM PHARMACEUTICAL INC
£ 427 M
Target: JNANA THERAPEUTICS
Bidder: OTSUKA PHARMACEUTICAL FACTORY INC
£ 875 M
Target: EXSCIENTIA
Bidder: RECURSION PHARMACEUTICALS
Target: ALIADA THERAPEUTICS
£ 1.08 B
Target: IDRX
56 Dealmakers
£ 941 M
Target: SCORPION THERAPEUTICS INC
31 Dealmakers
Target: EVERGREEN THERAGNOSTICS
Bidder: LANTHEUS
64 Dealmakers
£ 200 M
Target: SPRINGWORKS THERAPEUTICS
103 Dealmakers
£ 2.55 B
Target: VIGIL NEUROSCIENCE
£ 448 M
Target: SITEONE THERAPEUTICS INC
£ 737 M
Target: BLUEPRINT MEDICINES
89 Dealmakers
£ 6.76 B
Target: BOSTON PHARMACEUTICALS (BP ASSET IX / EFIMOSFERMIN)
Bidder: GSK PLC
£ 1.47 B
Target: CAPSTAN THERAPEUTICS
33 Dealmakers
£ 1.53 B
Target: VERONA PHARMA PLC
61 Dealmakers
£ 7.35 B
Target: Y-MABS THERAPEUTICS INC
Bidder: SERB PHARMACEUTICALS
£ 309 M
Target: ORBITAL THERAPEUTICS
£ 1.13 B
Target: HALDA THERAPEUTICS
Target: EXACT SCIENCES
Bidder: ABBOTT LABORATORIES
£ 16.02 B
Target: ARTHROSI THERAPEUTICS INC
Bidder: SWEDISH ORPHAN BIOVITRUM AB (SOBI)
£ 1.12 B
Target: AMICUS THERAPEUTICS
Bidder: BIOMARIN PHARMACEUTICAL INC
82 Dealmakers
£ 3.59 B
Target: DYNAVAX TECHNOLOGIES
66 Dealmakers
£ 1.63 B
Target: TANABE PHARMA CORP (RADICAVA BUSINESS)
Bidder: SHIONOGI
